NCT00329186View on ClinicalTrials.gov

Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects

PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Healthy
Interventions
DRUG

desvenlafaxine SR

DRUG

venlafaxine ER

Trial Locations (1)

67207

Wichita

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00329186 - Study Evaluating the Pharmacokinetics of Venlafaxine ER and Desvenlafaxine SR in Healthy Subjects | Biotech Hunter | Biotech Hunter